Black Diamond Therapeutics, Inc. (BDTX) vs BGM Group Ltd. (BGM)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and BGM Group Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.88HealthcareDelayed quote: Oct 6, 2026, 1:03 PM EDT
BGM
BGM Group Ltd.
$8.76HealthcareDelayed quote: Oct 6, 2026, 1:01 PM EDT
Total return — BDTX vs BGM
growth of $100 · dividends reinvested · last 2yBDTX -66.3% (-42.0%/yr)BGM -94.3% (-76.2%/yr)BDTX compounded faster over this window
Log scale — wide-divergence pair
BDTX BGM
BDTX vs BGM: by the numbers
- •BGM is the larger company ($111M vs $107M market cap).
- •BDTX is profitable (31.95% net margin) while BGM runs a net loss (-52.59%).
Metrics side by side
Valuation
| Metric | BDTX | BGM |
|---|---|---|
| P/B ratio | 1.12 | 0.28 |
Profitability
| Metric | BDTX | BGM |
|---|---|---|
| Gross margin | 99.54% | 12.79% |
| Operating margin | 28.39% | -33.18% |
| Net margin | 31.95% | -52.59% |
| ROE | -44.29% | -5.10% |
| ROIC | -47.54% | -3.19% |
Growth (annualized)
| Metric | BDTX | BGM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -5.39% |
| Total return CAGR (5Y) | -24.47% | N/A |
Frequently asked
- Is BDTX or BGM more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus BGM at -52.59%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.